News Daily News FDA Provides Update on Tainted ARB Investigation, With New Impurity Found Todd Neale March 04, 2019
News Daily News Alirocumab Price Cut Makes Second PCSK9 Inhibitor More Affordable Shelley Wood February 12, 2019
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Daily News ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom Michael O'Riordan November 07, 2018
News Daily News Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows Michael O'Riordan November 06, 2018
News Daily News FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now Michael O'Riordan November 01, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2018 Shelley Wood October 31, 2018
News Daily News Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors L.A. McKeown October 30, 2018
News Daily News Higher Fitness Again Tied to a Lower Risk of Death, Including CVD Mortality Michael O'Riordan October 30, 2018
News Daily News Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy Michael O'Riordan October 25, 2018
News Daily News More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery L.A. McKeown October 18, 2018
News Daily News CAC Scoring Is Predictive of Risk Across Races and Ethnicities L.A. McKeown October 16, 2018
News Daily News Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks Michael O'Riordan October 15, 2018
News Daily News Statin Benefits: Yes for CVD but No for Everything Else, Says New Review Michael O'Riordan October 08, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Daily News As Hypertension Sweeps China, Awareness, Treatment, and Control Remain Poor Todd Neale October 26, 2017
News Daily News Statins and Diabetes: Causal Link Reinforced in New Analysis Michael O'Riordan October 25, 2017